Patient characteristics, postadmission procedures and patient outcomes
n=19 926 | |
---|---|
Patient characteristics | |
Women, n (%) | 9884 (49.6) |
Age in years, mean±SD | 79.0±11.9 |
Route of admission, n (%) | |
Emergency with ambulance use | 6393 (32.1) |
Emergency without ambulance use | 9903 (49.7) |
Scheduled | 3630 (18.2) |
New York Heart Association functional class, n (%) | |
Class II | 5796 (29.1) |
Class III | 7318 (36.7) |
Class IV | 6812 (34.2) |
Comorbidities, n (%) | |
Hypertension | 10 588 (53.1) |
Ischaemic heart disease | 6120 (30.7) |
Atrial fibrillation/flutter | 5369 (26.9) |
Fatal arrhythmia | 385 (1.9) |
Shock | 321 (1.6) |
Postadmission treatments indicating disease severity, n (%) | |
Disease severity classes* | |
No target treatments provided | 16 079 (80.7) |
Catecholamine use only | 3090 (15.5) |
Intubation with no catecholamine use | 179 (0.9) |
Intubation with catecholamine use | 364 (1.8) |
Intra-aortic balloon pumping† | 194 (1.0) |
Percutaneous cardiopulmonary support‡ | 20 (0.1) |
Dialysis-related procedures | 790 (4.0) |
Blood transfusion | 1340 (6.7) |
Other postadmission high-cost examinations and treatments, n (%) | |
Percutaneous coronary intervention | 840 (4.2) |
Scintigraphy | 226 (1.1) |
Single-photon emission CT | 1840 (9.2) |
Patient outcomes | |
In-hospital mortality, n (%) | 1725 (8.7) |
Length of stay, days (mean; SD; median) | 19.9; 12.1; 17.0 |
Hospitalisation costs (US$) (mean; SD; median) | 8284; 7448; 6473 |
*These six disease-severity classes are based on hierarchical and mutually exclusive combinations.
†Regardless of intubation or catecholamine use.
‡Regardless of intra-aortic balloon pumping, intubation or catecholamine use.